Market Access Views & Analysis

Views & Analysis

Market access round-up: the UK opens up to innovation

When it comes to market access in the UK, the public’s eye has mostly been on the ongoing furore over Vertex’s cystic fibrosis drug

Digital

China in the fast lane

Brett Gardiner and Boon Yap from Research Partnership discuss access opportunities for novel therapies in the world’s hottest emerging market

Views & Analysis

UK pharma negotiating choppy seas during Brexit, says ABPI’s...

pharmaphorum caught up with Erik Nordkamp, outgoing president of the Association of the British Pharmaceutical Industry (ABPI), who has also changed role at Pfizer to become the organisatio

Views & Analysis

The challenge of transparency in the global supply chain

In the past year the pharmaceutical industry has witnessed an unprecedented number of drug recalls following the discovery that these products contained impurities, some of which are life t

Views & Analysis